Cuba’s Center for Drug Research and Development (CIDEM) and Russia’s Chemrar pharmaceutical group analyzed possible areas of collaboration, the Cuban scientific institution wrote on Twitter.
CIDEM is dedicated to the research and development of generic drugs, natural products, advanced technologies, and diagnostic means.
Being one of the scientific centers of the Group of Pharmaceutical and Biotechnological Industries of Cuba (BioCubaFarma), CIDEM has developed important products based on its technologies, which are part of the country’s therapeutic arsenal.
ChemRar is a group that unites investment and service companies in the field of innovative pharmaceuticals for the development and commercialization of drugs, diagnostics, preventive care, and new treatments for life-threatening diseases in Russia and abroad.
